Great Lakes NeuroTechnologies, which makes mobile software and wearable devices for monitoring symptoms of Parkinson's disease, has released a new clinical version of its technology that supports continuous monitoring. Kinesia 360 is still a clinician-facing tool; it doesn't appear to be the direct-to-consumer offering the company promised last April when it received a $1.5 million NIH grant.
"...
